Stay updated on CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Sign up to get notified when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.

Latest updates to the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry, Revision: v3.7.0, was added to the record history and the previous Revision: v3.6.6 entry was removed. This reflects an update to the documentation version without altering the study data shown on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe history log now shows a new latest revision (v3.6.6) replacing the previous v3.6.5, indicating an internal update to the page.SummaryDifference0.1%

- Check32 days agoChange DetectedThe Study Record History page shows a visual refresh with a revised layout and color-coded status areas. The underlying version list and textual changes appear unchanged, indicating a UI update rather than content updates.SummaryDifference0.1%

- Check39 days agoChange DetectedNo textual additions or deletions were provided in the change set. The page shows a history of status updates, but these changes are not captured in the submitted data.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.5 is now shown in the history, marking another update to the study record page. This is a metadata-level revision that does not alter the study data or its substantive content.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, and the previous revision entry (v3.6.3) was removed, reflecting an update to the study record's version history.SummaryDifference0.1%

Stay in the know with updates to CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Enter your email address, and we'll notify you when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.